Ohcanbohtosat - Isabelle Cleynen

Aiddostahte ozu
  1. 1
    Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?

    Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? Dahkki Ho‐Su Lee, Isabelle Cleynen

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease

    The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease Dahkki Tim Vanuytsel, Séverine Vermeire, Isabelle Cleynen

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    The HMGA proteins: A myriad of functions (Review)

    The HMGA proteins: A myriad of functions (Review) Dahkki Isabelle Cleynen, Wim Van de Ven

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Extracellular Vesicles in Inflammatory Bowel Disease: Small Particles, Big Players

    Extracellular Vesicles in Inflammatory Bowel Disease: Small Particles, Big Players Dahkki M Valter, Sare Verstockt, Julio Antonio Finalet Ferreiro, Isabelle Cleynen

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links

    Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links Dahkki Ho‐Su Lee, Evy Lobbestael, Séverine Vermeire, João Sabino, Isabelle Cleynen

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience Dahkki Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Genetic variation in the autophagy gene ULK1 and risk of Crohnʼs disease

    Genetic variation in the autophagy gene ULK1 and risk of Crohnʼs disease Dahkki Liesbet Henckaerts, Isabelle Cleynen, Marko Brinar, Jestinah Mahachie John, Kristel Van Steen, Paul Rutgeerts, Séverine Vermeire

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients

    Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients Dahkki Liesbet Henckaerts, Kristel Van Steen, Isabel Verstreken, Isabelle Cleynen, André Franke, Stefan Schreiber, Paul Rutgeerts, Séverine Vermeire

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease Dahkki Sare Verstockt, Bram Verstockt, Kathleen Machiels, Maaike Vancamelbeke, Marc Ferrante, Isabelle Cleynen, Gert De Hertogh, Séverine Vermeire

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn’s disease patients?

    TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn’s disease patients? Dahkki Bram Verstockt, Sare Verstockt, Helene Blevi, Isabelle Cleynen, Magali de Bruyn, Gert Van Assche, Séverine Vermeire, Marc Ferrante

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Carta
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis

    Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis Dahkki Maaike Vancamelbeke, Thessa Laeremans, Wiebe Vanhove, Kaline Arnauts, Anabela S. Ramalho, Ricard Farré, Isabelle Cleynen, Marc Ferrante, Séverine Vermeire

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

    A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease Dahkki Thomas Billiet, Konstantinos Papamichael, Magali de Bruyn, Bram Verstockt, Isabelle Cleynen, Fred Princen, Sharat Singh, Marc Ferrante, Gert Van Assche, Séverine Vermeire

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon

    Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon Dahkki Bram Verstockt, Sare Verstockt, Saeed Abdu Rahiman, Bo-Jun Ke, Kaline Arnauts, Isabelle Cleynen, João Sabino, Marc Ferrante, Gianluca Matteoli, Séverine Vermeire

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease Dahkki Maaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, Sare Verstockt, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Frans Schuit, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress

    Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress Dahkki Eveline Hoefkens, Kris Nys, Jestinah Mahachie John, Kristel Van Steen, Ingrid Arijs, Jan Van der Goten, Gert Van Assche, Patrizia Agostinis, Paul Rutgeerts, Séverine Vermeire, Isabelle Cleynen

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment

    Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment Dahkki Ingrid Arijs, Gert De Hertogh, Katleen Lemaire, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Peter Leemans, Isabelle Cleynen, Gert Van Assche, Séverine Vermeire, Karel Geboes, Frans Schuit, Paul Rutgeerts

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

    Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC Dahkki Ingrid Arijs, Gert De Hertogh, Bart Lemmens, Leentje Van Lommel, Magali de Bruyn, Wiebe Vanhove, Isabelle Cleynen, Kathleen Machiels, Marc Ferrante, Frans Schuit, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

    Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease Dahkki Matthias Jürgens, Jestinah Mahachie John, Isabelle Cleynen, Fabian Schnitzler, Herma H. Fidder, Wouter Van Moerkercke, Vera Ballet, Maja Noman, Ilse Hoffman, Gert Van Assche, Paul Rutgeerts, Kristel Van Steen, Séverine Vermeire

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease

    Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease Dahkki Wiebe Vanhove, Paul Peeters, Dominiek Staelens, Anica Schraenen, Jan Van der Goten, Isabelle Cleynen, Sebastiaan De Schepper, Leentje Van Lommel, Niki L. Reynaert, Frans Schuit, Gert Van Assche, Marc Ferrante, Gert De Hertogh, Emiel F.�M. Wouters, Paul Rutgeerts, Séverine Vermeire, Kris Nys, Ingrid Arijs

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Genetic variants in<i>CDC42</i>and<i>NXPH1</i>as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome

    Genetic variants in<i>CDC42</i>and<i>NXPH1</i>as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome Dahkki Mira M. Wouters, Diether Lambrechts, Michael Knapp, Isabelle Cleynen, Peter J. Whorwell, Lars Agréus, Aldona Dlugosz, Peter T. Schmidt, Jonas Halfvarson, Magnus Simrén, Bodil Ohlsson, Pontus Karling, Sander Van Wanrooy, Stéphanie Mondelaers, Séverine Vermeire, Greger Lindberg, Robert E. Spiller, George E. Dukes, Mauro D’Amato, Guy E. Boeckxstaens

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: